During the past decade, Kovai Diabetes Speciality Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kovai Diabetes Speciality Centre" are "Diabetes Mellitus" (4 trials), "Gastroparesis" (4 trials), "Type2 Diabetes" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Endocrine System Diseases" (1 trials). Many other conditions were trialed in "Kovai Diabetes Speciality Centre" in a lesser frequency.

Most popular intervention types in "Kovai Diabetes Speciality Centre" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (3 trials), "Glargine + Glulisine" (1 trials), "Premixed analogue insulin (70/30)" (1 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kovai Diabetes Speciality Centre" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kovai Diabetes Speciality Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kovai Diabetes Speciality Centre, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kovai Diabetes Speciality Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".